Biointaxis
Biointaxis is a genomic treatment and technology development company. The current lead program develops a gene therapy treatment for Friedreich ataxia, a rare, inherited, progressive neurodegenerative disease that typically affects teenagers and young adults. They reestablished the neurological functions in mice models of friedreich ataxia.
Tech Stack (11 technologies)
Frequently Asked Questions
What technologies does Biointaxis use?+
Biointaxis uses 11 technologies including Colorlib Shapely, OWL Carousel, WordPress.
What industry is Biointaxis in?+
Biointaxis operates in the Biotechnology industry.
Where is Biointaxis based?+
Biointaxis is headquartered in Spain.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026